Open AccessSurrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease
Author(s) -
B.M. Psaty,
N.S. Weiss,
C.D. Furberg,
T.D. Koepsell,
D.S. Siscovick,
F.R. Rosendaal,
N.L. Smith,
S.R. Heckbert,
D. Lin,
R.C. Kaplan,
T.R. Fleming,
E.H. Wagner
Publication year - 1999
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/k8vx-5d92
Subject(s) - medicine , disease , drug , intensive care medicine , surrogate endpoint , drug approval , pharmacology